Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression

References

• Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-44; PMID:10922424; http://dx.doi.org/10.1056/NEJM200008033430506
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22:240-73; PMID:19366914; http://dx.doi.org/10.1128/CMR.00046-08
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511; PMID:15229469; http://dx.doi.org/10.1038/nri1391
   PubMed Web of Science ®Google Scholar
• Pandey S, Agrawal DK. Immunobiology of Toll-like receptors: emerging trends. Immunol Cell Biol 2006; 84:333-41; PMID:16834572; http://dx.doi.org/10.1111/j.1440-1711.2006.01444.x
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007; 7:353-64; PMID:17457343; http://dx.doi.org/10.1038/nri2079
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84; PMID:20404851; http://dx.doi.org/10.1038/ni.1863
   PubMed Web of Science ®Google Scholar
• Ward PA. New approaches to the study of sepsis. EMBO Mol Med 2012; 4:1234-43; PMID:23208733; http://dx.doi.org/10.1002/emmm.201201375
   PubMedGoogle Scholar
• van der Poll T, van Zoelen MA, Wiersinga WJ. Regulation of pro-and anti-inflammatory host responses. Contrib Microbiol 2011; 17:125-36; PMID:21659750; http://dx.doi.org/10.1159/000324026
   PubMedGoogle Scholar
• Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8:776-87; PMID:18802444; http://dx.doi.org/10.1038/nri2402
   PubMed Web of Science ®Google Scholar
• Shaw AS, Filbert EL. Scaffold proteins and immune-cell signalling. Nat Rev Immunol 2009; 9:47-56; PMID:19104498; http://dx.doi.org/10.1038/nri2473
   PubMed Web of Science ®Google Scholar
• Moynagh PN. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol 2009; 30:33-42; PMID:19022706; http://dx.doi.org/10.1016/j.it.2008.10.001
   PubMed Web of Science ®Google Scholar
• Jensen LE, Whitehead AS. Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein. J Immunol 2003; 171:1500-6; PMID:12874243; http://dx.doi.org/10.4049/jimmunol.171.3.1500
   PubMedGoogle Scholar
• Butler MP, Hanly JA, Moynagh PN. Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner. J Biol Chem 2005; 280:27759-68; PMID:15917247; http://dx.doi.org/10.1074/jbc.M500756200
   PubMedGoogle Scholar
• Yang S, Wang B, Tang LS, Siednienko J, Callanan JJ, Moynagh PN. Pellino3 targets RIP1 and regulates the pro-apoptotic effects of TNF-α. Nat Commun 2013; 4:2583; PMID:24113711; http://dx.doi.org/10.1038/ncomms3583
   PubMedGoogle Scholar
• Mellett M, Atzei P, Jackson R, O’Neill LA, Moynagh PN. Mal mediates TLR-induced activation of CREB and expression of IL-10. J Immunol 2011; 186:4925-35; PMID:21398611; http://dx.doi.org/10.4049/jimmunol.1002739
   PubMedGoogle Scholar
• Schauvliege R, Janssens S, Beyaert R. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett 2006; 580:4697-702; PMID:16884718; http://dx.doi.org/10.1016/j.febslet.2006.07.046
   PubMedGoogle Scholar
• Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008; 283:33175-82; PMID:18772134; http://dx.doi.org/10.1074/jbc.M804478200
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13:722-37; PMID:24064518; http://dx.doi.org/10.1038/nri3532
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469:323-35; PMID:21248839; http://dx.doi.org/10.1038/nature09782
   PubMed Web of Science ®Google Scholar
• Ryter SW, Nakahira K, Haspel JA, Choi AM. Autophagy in pulmonary diseases. Annu Rev Physiol 2012; 74:377-401; PMID:22035347; http://dx.doi.org/10.1146/annurev-physiol-020911-153348
   PubMed Web of Science ®Google Scholar
• Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2:717-26; PMID:12951578; http://dx.doi.org/10.1038/nrd1177
   PubMed Web of Science ®Google Scholar
• Harris J. Autophagy and IL-1 Family Cytokines. Front Immunol 2013; 4:83; PMID:23577011; http://dx.doi.org/10.3389/fimmu.2013.00083
   PubMed Web of Science ®Google Scholar
• Huang YH, Tsai PS, Huang CJ. Bupivacaine inhibits COX-2 expression, PGE2, and cytokine production in endotoxin-activated macrophages. Acta Anaesthesiol Scand 2008; 52:530-5; PMID:18339158; http://dx.doi.org/10.1111/j.1399-6576.2008.01590.x
   PubMedGoogle Scholar
• Myeku N, Figueiredo-Pereira ME. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem 2011; 286:22426-40; PMID:21536669; http://dx.doi.org/10.1074/jbc.M110.149252
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the “a-B-cs” of plecomacrolide-induced neuroprotection. Autophagy 2006; 2:228-30; PMID:16874105; http://dx.doi.org/10.4161/auto.2703
   PubMed Web of Science ®Google Scholar
• Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8:397-403; PMID:9789328; http://dx.doi.org/10.1016/S0962-8924(98)01346-4
   PubMed Web of Science ®Google Scholar
• Allam US, Krishna MG, Sen M, Thomas R, Lahiri A, Gnanadhas DP, Chakravortty D. Acidic pH induced STM1485 gene is essential for intracellular replication of Salmonella. Virulence 2012; 3:122-35; PMID:22460643; http://dx.doi.org/10.4161/viru.19029
   PubMed Web of Science ®Google Scholar
• Nishiya T, Matsumoto K, Maekawa S, Kajita E, Horinouchi T, Fujimuro M, Ogasawara K, Uehara T, Miwa S. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins. J Biol Chem 2011; 286:9009-19; PMID:21199876; http://dx.doi.org/10.1074/jbc.M110.190678
   PubMedGoogle Scholar
• Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 1999; 96:10403-8; PMID:10468620; http://dx.doi.org/10.1073/pnas.96.18.10403
   PubMed Web of Science ®Google Scholar
• Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelárová H, Meijer AJ. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 1997; 243:240-6; PMID:9030745; http://dx.doi.org/10.1111/j.1432-1033.1997.0240a.x
   PubMedGoogle Scholar
• Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264-8; PMID:18849965; http://dx.doi.org/10.1038/nature07383
   PubMed Web of Science ®Google Scholar
• Liu Q, Xu C, Kirubakaran S, Zhang X, Hur W, Liu Y, Kwiatkowski NP, Wang J, Westover KD, Gao P, et al. Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. Cancer Res 2013; 73:2574-86; PMID:23436801; http://dx.doi.org/10.1158/0008-5472.CAN-12-1702
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584:1287-95; PMID:20083114; http://dx.doi.org/10.1016/j.febslet.2010.01.017
   PubMed Web of Science ®Google Scholar
• Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 2011; 10:868-80; PMID:22037041; http://dx.doi.org/10.1038/nrd3531
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ 3rd, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190:881-92; PMID:20819940; http://dx.doi.org/10.1083/jcb.200911078
   PubMed Web of Science ®Google Scholar
• Shaid S, Brandts CH, Serve H, Dikic I. Ubiquitination and selective autophagy. Cell Death Differ 2013; 20:21-30; PMID:22722335; http://dx.doi.org/10.1038/cdd.2012.72
   PubMed Web of Science ®Google Scholar
• Behrends C, Fulda S. Receptor proteins in selective autophagy. Int J Cell Biol 2012; 2012:673290; PMID:22536250; http://dx.doi.org/10.1155/2012/673290
   PubMedGoogle Scholar
• Grosshans J, Schnorrer F, Nüsslein-Volhard C. Oligomerisation of Tube and Pelle leads to nuclear localisation of dorsal. Mech Dev 1999; 81:127-38; PMID:10330490; http://dx.doi.org/10.1016/S0925-4773(98)00236-6
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137:1001-4; PMID:19524504; http://dx.doi.org/10.1016/j.cell.2009.05.023
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kageyama S, Ichimura Y. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 2012; 66:457-62; PMID:22841931; http://dx.doi.org/10.1016/j.phrs.2012.07.004
   PubMed Web of Science ®Google Scholar
• Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 2010; 584:1374-8; PMID:20153326; http://dx.doi.org/10.1016/j.febslet.2010.02.017
   PubMed Web of Science ®Google Scholar
• Korolchuk VI, Menzies FM, Rubinsztein DC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 2010; 584:1393-8; PMID:20040365; http://dx.doi.org/10.1016/j.febslet.2009.12.047
   PubMed Web of Science ®Google Scholar
• Shanware NP, Bray K, Abraham RT. The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease. Annu Rev Pharmacol Toxicol 2013; 53:89-106; PMID:23294306; http://dx.doi.org/10.1146/annurev-pharmtox-010611-134717
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J, Mizushima N, Ohsumi Y, Uchiyama Y, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169:425-34; PMID:15866887; http://dx.doi.org/10.1083/jcb.200412022
   PubMed Web of Science ®Google Scholar
• Wooten MW, Geetha T, Babu JR, Seibenhener ML, Peng J, Cox N, Diaz-Meco MT, Moscat J. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J Biol Chem 2008; 283:6783-9; PMID:18174161; http://dx.doi.org/10.1074/jbc.M709496200
   PubMed Web of Science ®Google Scholar
• Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7:279-96; PMID:21189453; http://dx.doi.org/10.4161/auto.7.3.14487
   PubMed Web of Science ®Google Scholar
• Watanabe-Asano T, Kuma A, Mizushima N. Cycloheximide inhibits starvation-induced autophagy through mTORC1 activation. Biochem Biophys Res Commun 2014; 445:334-9; PMID:24525133; http://dx.doi.org/10.1016/j.bbrc.2014.01.180
   PubMed Web of Science ®Google Scholar
• Sahani MH, Itakura E, Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy 2014; 10:431-41; PMID:24394643; http://dx.doi.org/10.4161/auto.27344
   PubMed Web of Science ®Google Scholar
• Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J, Diaz-Meco MT. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 2011; 44:134-46; PMID:21981924; http://dx.doi.org/10.1016/j.molcel.2011.06.038
   PubMed Web of Science ®Google Scholar
• Harris J, Hartman M, Roche C, Zeng SG, O’Shea A, Sharp FA, Lambe EM, Creagh EM, Golenbock DT, Tschopp J, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 2011; 286:9587-97; PMID:21228274; http://dx.doi.org/10.1074/jbc.M110.202911
   PubMed Web of Science ®Google Scholar
• Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012; 13:255-63; PMID:22286270; http://dx.doi.org/10.1038/ni.2215
   PubMed Web of Science ®Google Scholar
• Lopez-Castejon G, Luheshi NM, Compan V, High S, Whitehead RC, Flitsch S, Kirov A, Prudovsky I, Swanton E, Brough D. Deubiquitinases regulate the activity of caspase-1 and interleukin-1β secretion via assembly of the inflammasome. J Biol Chem 2013; 288:2721-33; PMID:23209292; http://dx.doi.org/10.1074/jbc.M112.422238
   PubMedGoogle Scholar
• Barker BR, Taxman DJ, Ting JPY. Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol 2011; 23:591-7; PMID:21839623; http://dx.doi.org/10.1016/j.coi.2011.07.005
   PubMed Web of Science ®Google Scholar
• Bryan NB, Dorfleutner A, Kramer SJ, Yun C, Rojanasakul Y, Stehlik C. Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes. J Inflamm (Lond) 2010; 7:23; PMID:20482797; http://dx.doi.org/10.1186/1476-9255-7-23
   PubMedGoogle Scholar
• Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009; 1793:664-73; PMID:18706940; http://dx.doi.org/10.1016/j.bbamcr.2008.07.014
   PubMed Web of Science ®Google Scholar
• Xia P, Wang S, Du Y, Zhao Z, Shi L, Sun L, Huang G, Ye B, Li C, Dai Z, et al. WASH inhibits autophagy through suppression of Beclin 1 ubiquitination. EMBO J 2013; 32:2685-96; PMID:23974797; http://dx.doi.org/10.1038/emboj.2013.189
   PubMed Web of Science ®Google Scholar
• Li H, Willingham SB, Ting JP, Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 2008; 181:17-21; PMID:18566365; http://dx.doi.org/10.4049/jimmunol.181.1.17
   PubMed Web of Science ®Google Scholar
• Abdul-Sater AA, Tattoli I, Jin L, Grajkowski A, Levi A, Koller BH, Allen IC, Beaucage SL, Fitzgerald KA, Ting JP, et al. Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome. EMBO Rep 2013; 14:900-6; PMID:24008845; http://dx.doi.org/10.1038/embor.2013.132
   PubMedGoogle Scholar